Urinary Excretion of Angiotensin Converting Enzyme in NIDDM Patients With Nephropathy
- Hiroyuki Hosojima, MD,
- Eiji Miyauchi, MD and
- Shinpei Morimoto, MD
- Division of Endocrinology, Department of Internal Medicine, Kanazawa Medical University Uchinada, Ishikawa, Japan
- Address correspondence and reprint requests to Hiroyuki Hosojima, MD, Division of Endocrinology, Department of Internal Medicine, Kanazawa Medical University, Uchinada, Ishikawa 920–02, Japan.
Abstract
Twenty-four-hour urinary excretion of angiotensinconverting enzyme (ACE) was investigated in relation to that of albumin and β2-microglobulin (β2M) in 25 noninsulin- dependent diabetes mellitus (NIDDM) patients without nephropathy, 13 NIDDM patients with incipient nephropathy, 18 NIDDM patients with overt nephropathy, and 14 nondiabetic subjects. NIDDM patients without nephropathy and nondiabetic subjects were similar in albumin, β2M, and ACE excretion. NIDDM patients with incipient nephropathy had elevated albumin excretion (P < .01) and similar (β2M and ACE excretion compared with nondiabetic subjects. On the other hand, NIDDM patients with overt nephropathy had elevated albumin, β2M, and ACE excretion compared with nondiabetic subjects (P < .01). In all NIDDM patients studied, a positive correlation was found between ACE excretion and albumin excretion (r = 0.76, P < .001) or β2M excretion (r = 0.52, P < .01). These data suggest that elevated ACE excretion in NIDDM patients with overt nephropathy may be reflective of renal tubular damage.
- Copyright © 1989 by the American Diabetes Association
